Amniotic bladder therapy in patients with recalcitrant interstitial cystitis and bladder pain syndrome.

Sophie Wittenberg, Raghav Madan, Aron Liaw, Steven Lucas, Alaa Hamada, Nivedita Dhar
{"title":"Amniotic bladder therapy in patients with recalcitrant interstitial cystitis and bladder pain syndrome.","authors":"Sophie Wittenberg, Raghav Madan, Aron Liaw, Steven Lucas, Alaa Hamada, Nivedita Dhar","doi":"10.5489/cuaj.8441","DOIUrl":null,"url":null,"abstract":"INTRODUCTION Bladder pain, urgency and frequency are common symptoms that are generally seen in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) [1]. These symptoms often arise due to excessive inflammation that disrupts the urothelial homeostasis and results in dysfunction of the bladder urothelium, which serves as a barrier to prevent injurious stimuli, toxins, or microorganisms from invading the stroma [2, 3]. Unfortunately, existing treatment options are palliative and do not modulate the underlying issues contributing to the symptoms. Hence, there remains an unmet clinical need for patients presenting with recalcitrant IC/BPS. Human amniotic membrane (AM) has been used in various clinical applications such as ocular and dermal wound healing due to its ability to modulate inflammation and promote tissue regeneration in the wound healing process [4, 5]. As AM has been shown to improve wound healing in many other medical practices, likewise it may improve urothelial wound healing in patients with recalcitrant IC/BPS. Herein, we detail the outcomes of five consecutive patients KEY MESSAGES","PeriodicalId":9574,"journal":{"name":"Canadian Urological Association journal = Journal de l'Association des urologues du Canada","volume":" ","pages":"E402-E404"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657225/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Urological Association journal = Journal de l'Association des urologues du Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5489/cuaj.8441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION Bladder pain, urgency and frequency are common symptoms that are generally seen in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) [1]. These symptoms often arise due to excessive inflammation that disrupts the urothelial homeostasis and results in dysfunction of the bladder urothelium, which serves as a barrier to prevent injurious stimuli, toxins, or microorganisms from invading the stroma [2, 3]. Unfortunately, existing treatment options are palliative and do not modulate the underlying issues contributing to the symptoms. Hence, there remains an unmet clinical need for patients presenting with recalcitrant IC/BPS. Human amniotic membrane (AM) has been used in various clinical applications such as ocular and dermal wound healing due to its ability to modulate inflammation and promote tissue regeneration in the wound healing process [4, 5]. As AM has been shown to improve wound healing in many other medical practices, likewise it may improve urothelial wound healing in patients with recalcitrant IC/BPS. Herein, we detail the outcomes of five consecutive patients KEY MESSAGES
难治性间质性膀胱炎及膀胱疼痛综合征患者的羊膜膀胱治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信